NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Roblox Corporation ("Roblox" or "the Company") (NYSE:RBLX). Investors who purchased Roblox securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RBLX. Investigation Details […]

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JFrog Ltd. ("JFrog" or "the Company") (NASDAQ:FROG). Investors who purchased JFrog securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FROG. Investigation Details On

NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Torrid Holdings Inc. ("Torrid" or "the Company") (NYSE:CURV). Investors who purchased Torrid securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CURV. Investigation

NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ACHC.

NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nomura Holdings Inc ADR ("Nomura" or "the Company") (NYSE:NMR). Investors who purchased Nomura securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NMR.

NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. ("Travere" or "the Company") (NASDAQ:TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TVTX. Investigation

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Spire Global, Inc. (NYSE: SPIR) between March 6, 2024 and August 14, 2024, both dates inclusive (the “Class Period”), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) between May 17, 2022 and July 19, 2024, both dates inclusive (the “Class Period”), of the important November 12, 2024 lead plaintiff deadline. SO WHAT: If you

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Endava To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $100,000in Endava between May 23, 2023, and February 28, 2024 and would

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Metagenomi To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $50,000 in Metagenomi between February 9, 2024 and September 26, 2024 and